TCL Archive Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials. May 11, 2001
TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout September 18, 1998
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014
